Seoul, South Korea

Ji-seong Yoon

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Korea Institute of Science and Technology. Active years: 2014.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ji-seong Yoon: Innovator in Biomarker Identification

Introduction

Ji-seong Yoon is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biomarker identification, particularly in relation to lower aliphatic saturated aldehydes. His innovative work has implications for both monitoring exposure and assessing risks associated with these compounds.

Latest Patents

Ji-seong Yoon holds a patent for "Micro RNAs for identification of exposure to lower aliphatic saturated aldehydes and the method of identification using thereof." This invention focuses on utilizing micro RNA as a biomarker to identify exposure to lower aliphatic saturated aldehydes. The patent describes a method that involves selecting micro RNAs that are either up-regulated or down-regulated in response to exposure. These micro RNAs serve as effective tools for monitoring exposure and investigating the mechanisms of toxicity.

Career Highlights

Ji-seong Yoon is affiliated with the Korea Institute of Science and Technology, where he conducts research and development in the field of biomarker identification. His work has garnered attention for its potential applications in environmental health and safety.

Collaborations

Some of his notable coworkers include Jae Chun Ryu and Mee Kyung Song. Their collaborative efforts contribute to advancing research in the field of biomarker identification.

Conclusion

Ji-seong Yoon's innovative work in the identification of biomarkers for exposure to lower aliphatic saturated aldehydes highlights his significant contributions to science and technology. His research not only aids in monitoring exposure but also enhances our understanding of the associated risks.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…